Skip to main content
All lobbying clients

Independent Pharmacy Cooperative

Independent Pharmacy Cooperative has lobbied on its own behalf and been represented by 1 lobbying firm in 14 filings since 2025, with $540,000 in reported spending; the newest was posted October 18, 2026.

As filed: INDEPENDENT PHARMACY COOPERATIVE. Client based in Wisconsin.

Largest group purchasing organization for independent pharmacies.

$540,000 Reported spend
14 Filings counted
1 Outside firm hired
20 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 20
  • S. 927
    Protecting Pharmacies in Medicaid Act
    13 filings
  • H.R. 4317
    PBM Reform Act of 2025
    10 filings
  • S. 2426
    Equitable Community Access to Pharmacist Services Act
    7 filings
  • S. 891
    Bipartisan Health Care Act
    7 filings
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
    6 filings
  • S. 3822
    Break Up Big Medicine Act
    6 filings
  • H.R. 5256
    340B ACCESS Act
    4 filings
  • H.R. 6609
    Pharmacists Fight Back in Medicare and Medicaid Act
    4 filings
  • H.R. 6610
    Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
    4 filings
  • S. 3345
    PBM Price Transparency and Accountability Act
    4 filings
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
    4 filings
  • S. 527
    Prescription Pricing for the People Act of 2025
    4 filings
  • S. 882
    Patients Before Middlemen Act
    3 filings
  • S. 2477
    Equitable Community Access to Pharmacist Services Act
    2 filings
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    2 filings
  • H.R. 5316
    Drug Shortage Compounding Patient Access Act of 2025
    2 filings
  • H.R. 6509
    SAFE Drugs Act of 2025
    2 filings
  • S. 3794
    SAFE Drugs Act of 2026
    2 filings
  • H.R. 1
    One Big Beautiful Bill Act
    1 filing
  • H.R. 879
    Medicare Patient Access and Practice Stabilization Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $250,000 6 filings
  • 2025 $290,000 8 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
  • Centers For Medicare and Medicaid Services (CMS) 7
  • White House Office 4
  • Health Resources & Services Administration (HRSA) 3
  • Labor, Dept of (DOL) 2
 Recent filings 14 total
Q3 report
Forbes-Tate
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 18, 2026
View → Q3 report
Independent Pharmacy Cooperative
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 expenses · posted Oct 8, 2026
View → Q2 report
Forbes-Tate
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View → Q2 report
Independent Pharmacy Cooperative
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 expenses · posted Jul 14, 2026
View → Q1 report
Forbes-Tate
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 20, 2026
View → Q1 report
Independent Pharmacy Cooperative
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 expenses · posted Apr 16, 2026
View → Q4 report
Forbes-Tate
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 18, 2026
View → Q4 report
Independent Pharmacy Cooperative
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 expenses · posted Jan 9, 2026
View → Q3 report
Forbes-Tate
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 18, 2025
View → Q3 report
Independent Pharmacy Cooperative
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 expenses · posted Oct 16, 2025
View → Q2 report
Forbes-Tate
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 18, 2025
View → Q2 report
Independent Pharmacy Cooperative
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 expenses · posted Jul 17, 2025
View → Q1 report
Forbes-Tate
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 15, 2025
View → Q1 report
Independent Pharmacy Cooperative
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 expenses · posted Apr 12, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem